The FDA has authorized fall COVID-19 boosters, and now the shots have just received the CDC’s signoff before they can get in the pipeline for widespread distribution. It is expected that they will hit pharmacies within days.
The booster shots will be a mix of the original form of COVID-19, along with omicron subvariants. This allows them to target omicron — especially BA.5, the dominant strain in the U.S. right now — in a way that the previous shots, which were made before omicron came on the scene, were not as able to do. While the previous shots still provide excellent protection against severe illness, these will offer a
→ Continue reading at MyNorthwest